Carl Icahn, William Ackman, and a Seven-Year Fight Over “Pennies”

In one corner is Carl C. Icahn, the corporate raider who made C.E.O.’s tremble back in the 1980s and, at 75, is still chasing deals.

In the other is William A. Ackman, 45, one of Mr. Icahn’s figurative heirs and a leading practitioner of the bruising, Icahnesque craft politely known as activist investing.

These ultrarich men battled for seven years in multiple courts, over a relatively paltry $4.5 million. That might be real money to mere mortals, but to these two, it’s barely a rounding error.

So why bother? This battle, it turns out, was more about big egos than big money.

Well, it will be difficult to find billionaires without big egos, but it might be more difficult to find billionaires wasting their time for small pieces of money to satisfy their egos.

More of this saucy story from here

Alex Denner, earlier with Icahn, $2 Billion Man Starts Biotech Hedge Fund

Alex Denner knows how to spot biotechnology companies with promising drugs and make sure investments pay off.

Working as Carl Icahn’s top health-care investing executive for the past five years, Denner has targeted at least six drugmakers from ImClone Systems Inc. to Biogen Idec Inc. (BIIB), prompting sales of three. He’s generated about $2 billion in profit for Icahn, said a person familiar with his record who declined to be identified because the matter is private.

Now the 42-year-old Denner, who has a Ph.D. in biomedical engineering, is splitting with Icahn to start his own hedge fund. As some investors avoid health care, partly because of regulatory hurdles, Denner’s knowledge of science and business gives him an advantage as one of the industry’s few activists

More from here

105 Billion Dollar ObamaCare Secret